Sep 2026· Annals of Surgical Oncology· 1 citation· 17 references
Medicine
TL;DR
After additional adjustment for cT, cN, and cM, bulky status was no longer significantly associated with DFS or OS and did not improve model fit, but its incremental prognostic value beyond cTNM staging appears limited.
Although PORT did not significantly improve survival in the overall cSCLN+ population, a trend toward improved OS was observed in the cSCLN+pSCLN+ subgroup, suggesting PORT may be considered as a potential strategy to improve survival outcomes.
Yi-Meng Yu, Lin Lin, Ya Zeng et al.· Annals of Surgical Oncology· 0 citations
In patients achieving ypN0, pre-treatment cN did not demonstrate statistically significant additional prognostic discrimination in this cohort, although estimates were imprecise due to the small cN+/ypN0 subgroup and limited events.
He-Rui Han, Xiao-Bin Hou, Yi-Ming Liu et al.· Frontiers in Oncology· 0 citations
Standard ypTNM staging may not capture residual viable tumor (RVT) across primary and nodal sites after neoadjuvant immunochemotherapy (NICT) for locally advanced oral squamous cell carcinoma (OSCC). Our aim was to derive and internally evaluate a composite RVT score. This retrospective cohort study was conducted at a...
Ye-Qing Zhou, Lan Ma, Ying Dai et al.· Journal of cranio-maxillo-fa...· 0 citations
CT-based staging of the clinically node-negative (cN0) neck in oral squamous cell carcinoma (OSCC) has limited sensitivity, and occult nodal metastasis remains common. Whether the CT-to-surgery interval influences pathological nodal outcome is unclear. This retrospective study included 329 patients with primary cN0 OSC...
J. Ketschau, J. Mohr, A. Grabenhorst et al.· Journal of Cancer Research a...· 0 citations
Pretreatment MRI-defined necrotic nodal phenotypes provide additional risk stratification beyond LNN alone and may identify a subgroup of N3 NPC patients with increased risk of distant metastasis.
Yu-Wei Wang, Kai-Yun You, Xiao-Wen Lan et al.· Oral Oncology· 1 citation
BACKGROUND
After neoadjuvant therapy for esophageal squamous cell carcinoma, pathologic nodal staging counts metastatic nodes without capturing their anatomic distribution and is susceptible to stage migration. We evaluated whether involved lymph node station count improves 3-year distant metastasis prediction beyond c...
Jia-Huang Hong, Pei-Yuan Wang, Xiao-Yong Liu et al.· Annals of Thoracic Surgery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.